Stockreport

AbbVie abandons late-stage lung cancer asset Rova-T [Reuters (UK)]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF AbbVie abandons late-stage lung cancer asset Rova-T - Reuters 2 Min Read (Reuters) - AbbVie Inc said on Thursday it will cease to develop its experimental drug Rova-T af [Read more]